MicroRNA-139 modulates Alzheimer's-associated pathogenesis in SAMP8 mice by targeting cannabinoid receptor type 2

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Alzheimer's disease (AD) is a leading cause of dementia in older adults.
• MicroRNAs (miRNAs) are implicated in the neuroinflammation characteristic of AD progression.

Purpose of the Study:

• To investigate the role of microRNA-139 (miR-139) in Alzheimer's disease (AD).
• To analyze the relationship between miR-139 expression, cognitive function, and neuroinflammation in an AD mouse model.

Main Methods:

• Expression analysis of miR-139 in the hippocampus of senescence accelerated mouse prone 8 (SAMP8) mice and control mice.
• Assessment of learning and memory functions following miR-139 manipulation (overexpression and downregulation) in the hippocampus.
• Correlation analysis between miR-139 levels and cannabinoid receptor type 2 (CB2) expression in primary hippocampal cells.
• Evaluation of miR-139's effect on neuroinflammatory responses.

Main Results:

• miR-139 expression was significantly higher in the hippocampus of aged SAMP8 mice compared to controls.
• Overexpression of miR-139 impaired hippocampus-dependent learning and memory.
• Downregulation of miR-139 improved learning and memory function.
• CB2 receptor levels were inversely correlated with miR-139 expression.
• miR-139 modulated responses to proinflammatory stimuli.

Conclusions:

• miR-139 plays a pathogenic role in Alzheimer's disease.
• miR-139 exacerbates AD by modulating CB2-mediated neuroinflammatory pathways.
• Targeting miR-139 may offer a therapeutic strategy for AD treatment.